Locations:
Search IconSearch

Tag: CAR-T cell therapy

CAR T-cell therapy
December 9, 2024/Cancer/Blood Cancers

Major Study Finds CAR T-Cell Therapy Safe and Effective for Older Patients With B-Cell Acute Lymphoblastic Leukemia

Offers a new option for patients 60 and older with relapsed/refractory disease

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Diffuse large B-cell lymphoma
August 1, 2024/Cancer/Research

Emerging Second- and Third-Line Treatments Improve Outcomes in Diffuse Large B-Cell Lymphoma

CAR T-cell therapy, bispecifics and antibody drug conjugates have changed disease management

car T-cells
June 3, 2024/Cancer/Blood Cancers

CAR T-Cell Treatment Offers Hope for Richter Transformation

Real-world study shows high response rates that are durable with commercial lisocabtagene maraleucel

CAR T-cells
December 15, 2023/Cancer/Blood Cancers

CAR T-Cell Therapy Effective in Refractory Double-Hit/Triple-Hit Lymphoma

Two thirds of patients responded to CAR T-cell therapy

CAR T-cell therapy
April 5, 2023/Cancer/Blood Cancers

Insights About CAR T-Cell Therapy

Dispelling myths and sharing practical experiences

T-cells_650x450
December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

BackPage 2 of 3Next

Advertisement

Ad